Why not change the therapy of hypertension in patients with COVID-19. Dual role of angiotensin-converting enzyme 2

Jerzy Głuszek, Teresa Kosicka

PDF HTML

COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

Ahmed Nafakhi, Ihsan Rabeea, Rasha AL-Darraji, Hussein Nafakhi, Ahmed Mechi, Alhan Al-khalidi

Original paper

PDF HTML

Early detecting myocardial entity damage using 2D speckle tracking echocardiography through strain parameters in hypertensive patients

Thị Nguyễn Diễm, Vũ Anh Nguyễn, Lợi Doãn Đỗ, Nhân Hữu Kha, An Viết Trần, Quốc Lâm Thiện Huỳnh, Bảo Lâm Thái Trần, Quan Nhất Kỳ Nguyễn

Original paper

PDF HTML

Leptin in obesity and hypertension

Hilal Bhat, Javaid Ahmad Bhat, Moomin Hussain Bhat, Masrat Rashid, Rafi Jan, Dil Afroze

Original paper

PDF HTML

Effectiveness of a self-management education program on hypertension control and contributing factors in older adults: an interventional trial

Elaheh Foroumandi, Mohammad Alizadeh, Omid Nikpayam, Sorayya Kheirouri

Original paper

PDF HTML

Drug resistant hypertension and Munchausen syndrome

Malgorzata Wierzowiecka, Iwona Smolarek, Karolina Niklas, Andrzej Tykarski, Arkadiusz Niklas

Case report

PDF HTML